Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Tiger Investment Representatives
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

14.77
+0.72005.12%
Pre-market: 14.64-0.1300-0.88%07:38 EDT
Volume:2.97M
Turnover:43.62M
Market Cap:1.39B
PE:-4.68
High:14.98
Open:13.88
Low:13.81
Close:14.05
52wk High:15.71
52wk Low:1.50
Shares:94.22M
Float Shares:77.49M
Volume Ratio:0.92
T/O Rate:3.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1550
EPS(LYR):-3.3828
ROE:-134.29%
ROA:-51.30%
PB:13.17
PE(LYR):-4.37

Loading ...

OverviewCompanyNewsFilings

FDA, in Complete Response Letter: Data Was Insufficient to Conclude Substantial Evidence of Effectiveness of Replimune's Vusolimogene Oderparepvec

THOMSON REUTERS
·
Apr 10

US FDA declines to approve Replimune's drug for advanced skin cancer

Reuters
·
Apr 10

Replimune sinks after FDA issues complete response letter

TIPRANKS
·
Apr 10

Replimune halted for news after dropping 19% to $4.76

TIPRANKS
·
Apr 10

Replimune Group trading halted, volatility trading pause

TIPRANKS
·
Apr 10

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:53 AM

Reuters
·
Apr 10

FDA Review Looms As Replimune Faces Weak Technical Setup

Benzinga_recent_news
·
Apr 09

Replimune Chief Commercial Officer Christopher Sarchi sells USD 52,065 common shares

Reuters
·
Apr 07

MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines -- Heard on the Street -- WSJ

Dow Jones
·
Mar 03

Analyst Rate

Buy
Buy
87.50%
Hold
0.00%
Sell
12.50%

Corporate Actions

Financial Report Announcement
Aug 14, 2026 Pre-MKt
Financial Report Announcement
Jun 29, 2026 Pre-MKt
Financial Report Announcement
Feb 03, 2026 Pre-MKt
Financial Report Announcement
Nov 06, 2025 Pre-MKt
Financial Report Announcement
Aug 07, 2025 Pre-MKt

Dividend History

no data

No relevant data is available

Valuation Analysis

-4.68
Current
-5.35
Sector Average
47.25%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-4.68
Maximum
-0.57
+1 STD
-1.52
Minimum
-16.99
-1 STD
-9.17
Average
-5.35

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.